Building India's most trusted prescription-only dermatology brand — one clinical protocol at a time.
Every Arionix product is formulated exclusively for prescription use. We do not operate in the OTC channel. Your patients receive what only a dermatologist can prescribe.
Our product protocols are designed in consultation with practising dermatologists. We build products around real clinical scenarios, not retail demand.
Each formulation is built on peer-reviewed evidence. Actives are chosen for clinical efficacy, optimal concentration, and demonstrated patient tolerance.
Arionix Laboratories is a prescription-only dermatology pharmaceutical company committed to elevating the standard of dermatological treatment in India.
Operating under Aradhana Pharmaceuticals, headquartered in Gurugram, Haryana, every product we create has one purpose — to give dermatologists a brand they can trust completely.
We do not launch products for the sake of portfolio size. Every SKU we launch has a defined clinical role, a defined patient profile, and a defined position in a dermatologist's treatment sequence.
Before any product is developed, we map the clinical protocol it belongs to. Each product is a piece of a larger treatment system — not a standalone SKU.
Arionix products are never sold over the counter. We protect the dermatologist's authority and the patient's safety. We will never compromise this position.
Each active is chosen for proven clinical efficacy, appropriate concentration, and demonstrated patient tolerance. We follow the science, not the trend.
All Arionix products are manufactured at WHO-GMP certified pharmaceutical plants, meeting the highest standards of quality, safety, and regulatory compliance. Our manufacturing partners are fully compliant with Schedule M requirements under the Drugs and Cosmetics Act.
A Division of Aradhana Pharmaceuticals
The Roselia, 06 GF, Sector 95A
Gurugram — 122505, Haryana, India
info@arionixlabs.com
+91-7985759455
www.arionixlabs.com
Carefully formulated. Clinically mapped. Made for prescription practice.
Compromised, dry & sensitive skin. Atopic dermatitis, eczema, steroid-damaged skin, and post-procedure barrier support.
Suitable for all skin types. Gently removes excess oil and impurities, helps unclog pores, reduces breakouts, and maintains skin balance and hydration.
In protocols. In sequences. In clinical outcomes. Not in SKUs.
Every Arionix SKU is mapped to a specific position in a clinical protocol. Products are designed to work together as a coherent treatment system — not as isolated brands competing for the same prescription.
Arionix products are never available over the counter. Your prescription carries clinical authority. We protect that authority by ensuring our products can only reach patients through you.
Our product literature clearly states every active, its concentration, its mechanism, and its clinical evidence base. If a formulation cannot be justified clinically, it does not get launched.
All products are manufactured at WHO-GMP and Schedule M compliant facilities, ensuring the batch your patient receives meets the same standard every time.
Evidence-based insights for dermatology practice.
Skin barrier dysfunction underlies atopic dermatitis, eczema, steroid-damaged skin, and poor treatment tolerance. Here is why barrier repair should be routine in every treatment plan.
The cleanser is the most underestimated product in a dermatology protocol. Here is why the right face wash matters significantly for treatment outcomes.
Melasma is the most mismanaged condition in Indian dermatology. Here is why standard approaches fall short and what a complete protocol looks like.
The biggest reason melasma and PIH relapse is sunscreen non-compliance. Here is the clinical evidence and how dermatologists can improve patient adherence.
The skin barrier — the stratum corneum and its lipid matrix of ceramides, fatty acids, and cholesterol — is the first line of defence against environmental triggers, allergens, and transepidermal water loss. When this barrier is compromised, everything else in the treatment plan becomes harder to achieve.
Barrier dysfunction is central to atopic dermatitis, but it is also a clinically significant issue in patients on prolonged topical steroid therapy, those undergoing chemical peels or laser procedures, patients with chronic eczema, and those with naturally dry or sensitive skin types.
Ceramides are the primary lipid component of the skin barrier and are significantly reduced in atopic skin. Supplementing barrier lipids through a ceramide-based moisturiser is an evidence-based intervention that reduces flare frequency, improves patient comfort, and allows other active treatments to work more effectively.
Niacinamide and Polyglutamic Acid complement ceramide supplementation by stimulating endogenous ceramide synthesis, reducing transepidermal water loss, and supporting the skin's natural hydration mechanisms.
Barrier repair should not be an afterthought in a treatment plan. For patients with atopic dermatitis, post-procedure skin, or any condition involving barrier compromise, a dedicated barrier repair moisturiser is as important as the active treatment prescribed alongside it.
The cleanser is often the first product a dermatology patient uses every day, yet it is frequently the last thing discussed in a consultation. This is a missed clinical opportunity. The wrong cleanser — too harsh, too stripping, or with inappropriate actives — can undermine an otherwise well-designed treatment plan.
For patients with acne-prone or oily skin, a salicylic acid-based foaming cleanser offers several clinical advantages. Salicylic acid is a beta-hydroxy acid that is lipophilic, allowing it to penetrate into sebaceous follicles and dissolve the comedonal plug that initiates acne formation.
The choice of cleanser also directly impacts skin barrier health. Overly alkaline cleansers disrupt the skin's natural acid mantle, increasing susceptibility to bacterial colonisation and transepidermal water loss. A pH-balanced cleanser maintains the acid mantle while delivering its active benefits.
D-Panthenol, included as a humectant and barrier-supporting ingredient, counterbalances the potential drying effect of salicylic acid, making the formulation more tolerable for daily use across all skin types.
Melasma is the single most common pigmentary disorder presenting in Indian dermatology OPDs. Yet it remains one of the most poorly managed. Why? Because most treatment approaches address only one part of the problem.
Melasma is a multifactorial condition. UV radiation, hormonal triggers, heat, inflammation, and genetic predisposition all contribute. A complete protocol must address all three pillars simultaneously: photoprotection, active depigmentation, and systemic support where indicated.
Photoprotection is non-negotiable. Indian skin faces year-round UV exposure across UVB and UVA spectra. A sunscreen with minimum SPF 50+ and PA++++ rating must be the foundation of every melasma protocol.
Topical depigmentation should target melanin synthesis at multiple steps. A combination topical addressing multiple pathways delivers superior results over monotherapy. Systemic adjuvants such as Tranexamic Acid add a meaningful additional layer of treatment in refractory cases.
Every dermatologist knows the pattern. You prescribe a complete melasma protocol. The patient returns three months later with full relapse. When asked about sunscreen, the answer is almost always the same: it felt too heavy, it left a white cast, or it was discontinued after a few weeks.
The most common reason for non-compliance in Indian skin types is cosmetic elegance. Indian patients, particularly those with Fitzpatrick types III–V, are highly sensitive to the sensory profile of a sunscreen. A greasy or white-cast formula will be abandoned within weeks regardless of its SPF rating.
The prescription choice matters significantly. A dermatologist-recommended sunscreen carries far greater compliance than one self-selected at a pharmacy. When dermatologists prescribe a specific, named product with clear instructions, compliance improves measurably.
We welcome feedback, suggestions, and professional enquiries from dermatologists, healthcare professionals, and trade partners.